Abstract
Successful treatment of persistent empyema by intrapleural streptokinase is described in five pediatric patients. Their ages ranged from 18 months to 7 years. All experienced dramatic improvement in the resolution of their empyemas following intrapleural streptokinase. Improved chest tube drainage occurred concurrently with clinical improvement. Intrapleural instillation of streptokinase appears to be a safe adjunctive therapeutic tool to facilitate drainage of persistent empyema in the small number of pediatric patients in whom it has been employed. Additional study will be required to further assess the long-term therapeutic efficacy and consequences of intrapleural streptokinase therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
